Lv2
160 积分 2025-02-07 加入
Analytical agreement and platform-specific decision thresholds for plasma p-tau217 measured on Lumipulse G600II and Cobas e801 in a paired CSF-plasma cohort
19小时前
待确认
2025 China's Progress in Alzheimer's Disease: Prevention, Diagnosis, and Treatment
1个月前
已关闭
Large-scale plasma proteomic profiling identifies a high-performance biomarker panel for Alzheimer's disease screening and staging
1个月前
已关闭
Head-to-head comparison of plasma biomarker assays across platforms for amyloid pathology in a multicenter cohort
1个月前
已完结
Tau Protein Quantification in Human Cerebrospinal Fluid by Targeted Mass Spectrometry at High Sequence Coverage Provides Insights into Its Primary Structure Heterogeneity
2个月前
已完结
Comparison of diagnostic accuracy of Alzheimer's disease cerebrospinal fluid core biomarkers using INNOTEST, Lumipulse G, and Elecsys assays: Insights from the PUMCH dementia cohort study
3个月前
已完结
Blood Biomarkers to Detect Alzheimer Disease in Primary Care and Secondary Care
4个月前
已完结
Performance of plasma phosphorylated tau 181 and 217 in the community
5个月前
已完结
A rapid and novel quantitative determination of Lecanemab monoclonal antibody for Alzheimer’s disease using reverse phase ultra performance liquid chromatography
6个月前
已完结
皖公网安备34019202002308
